AQST Q1 2021 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11M+26.9% YoY

Gross Profit

$8M75.2% margin

Operating Income

-$9M-76.6% margin

Net Income

-$15M-131.9% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+55.6%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$62M

Total Liabilities

$114M

Stockholders' Equity

-$52M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$9M	+26.9%
Gross Profit	$8M	$5M	+63.8%
Operating Income	-$9M	-$14M	+38.5%
Net Income	-$15M	-$17M	+11.2%

Revenue Segments

Manufacture and Supply Revenue

$7M73%

License and Royalty Revenue

$2M27%